[go: up one dir, main page]

WO2011139118A3 - A pharmaceutical composition and a health functional food composition for preventing, treating or improving a gastrointestinal dyskinetic disease - Google Patents

A pharmaceutical composition and a health functional food composition for preventing, treating or improving a gastrointestinal dyskinetic disease Download PDF

Info

Publication number
WO2011139118A3
WO2011139118A3 PCT/KR2011/003397 KR2011003397W WO2011139118A3 WO 2011139118 A3 WO2011139118 A3 WO 2011139118A3 KR 2011003397 W KR2011003397 W KR 2011003397W WO 2011139118 A3 WO2011139118 A3 WO 2011139118A3
Authority
WO
WIPO (PCT)
Prior art keywords
gastrointestinal
functional food
health functional
rhizoma
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2011/003397
Other languages
French (fr)
Other versions
WO2011139118A2 (en
Inventor
Young Ryool Kim
Il Hwan Cho
Geun Seog Song
Byoung Seok Moon
Chi Hye Park
Young Mee Chung
Oh Eok Kwon
Ye Kyung Cho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCIGREEN
CJ CheilJedang Corp
Original Assignee
SCIGREEN
CJ CheilJedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCIGREEN, CJ CheilJedang Corp filed Critical SCIGREEN
Priority to BR112012020342A priority Critical patent/BR112012020342A2/en
Priority to RU2012134195/15A priority patent/RU2540511C2/en
Priority to UAA201209654A priority patent/UA105685C2/en
Priority to CN2011800084088A priority patent/CN102858357A/en
Priority to PH1/2012/501555A priority patent/PH12012501555A1/en
Publication of WO2011139118A2 publication Critical patent/WO2011139118A2/en
Publication of WO2011139118A3 publication Critical patent/WO2011139118A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718—Coptis (goldthread)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a pharmaceutical composition for the prevention or treatment of gastrointestinal dyskinetic diseases and a health functional food composition for the prevention or improvement of gastrointestinal dyskinetic diseases, comprising a combination of two or more selected from the group consisting of Bupleuri Radix, Coptidis Rhizoma and Glycyrrhizae Radix et Rhizoma. The composition according to the present invention comprises a combination of two or more of Bupleuri Radix, Coptidis Rhizoma and Glycyrrhizae Radix et Rhizoma, and significantly facilitates gastrointestinal motility, in particular, gastric emptying rate and gastrointestinal transit, thereby being used for the prevention, improvement, or treatment of gastrointestinal dyskinetic diseases, in particular, functional dyspepsia associated with gastric emptying rate or gastrointestinal transit. In addition, the composition according to the present invention consists of natural substances, and thus there is little concern regarding undesirable toxicity.
PCT/KR2011/003397 2010-05-06 2011-05-06 A pharmaceutical composition and a health functional food composition for preventing, treating or improving a gastrointestinal dyskinetic disease Ceased WO2011139118A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BR112012020342A BR112012020342A2 (en) 2010-05-06 2011-05-06 pharmaceutical composition and composition of health functional foods for prevention, treatment or amelioration of a dyskinetic gastrointerstinal disease.
RU2012134195/15A RU2540511C2 (en) 2010-05-06 2011-05-06 Pharmaceutical composition and food functional therapeutic composition for preventing, treating or relieving gastrointestinal dysmotilities
UAA201209654A UA105685C2 (en) 2010-05-06 2011-05-06 Pharmaceutical composition and a health functional food composition for preventing, treating or improving a gastrointestinal dyskinetic disease
CN2011800084088A CN102858357A (en) 2010-05-06 2011-05-06 Pharmaceutical composition and health functional food composition for preventing, treating or improving gastrointestinal motility disorders
PH1/2012/501555A PH12012501555A1 (en) 2010-05-06 2011-05-06 A pharmaceutical composition and a health functional food composition for preventing, treating, or improving a gastrointestinal dyskinetic disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0042585 2010-05-06
KR1020100042585A KR101263191B1 (en) 2010-05-06 2010-05-06 A pharmaceutical composition and a health functional food composition for preventing, treating or improving a gastrointestinal dyskinetic disease

Publications (2)

Publication Number Publication Date
WO2011139118A2 WO2011139118A2 (en) 2011-11-10
WO2011139118A3 true WO2011139118A3 (en) 2012-04-19

Family

ID=44904245

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/003397 Ceased WO2011139118A2 (en) 2010-05-06 2011-05-06 A pharmaceutical composition and a health functional food composition for preventing, treating or improving a gastrointestinal dyskinetic disease

Country Status (8)

Country Link
KR (1) KR101263191B1 (en)
CN (2) CN104800309A (en)
BR (1) BR112012020342A2 (en)
MY (1) MY162542A (en)
PH (1) PH12012501555A1 (en)
RU (1) RU2540511C2 (en)
UA (1) UA105685C2 (en)
WO (1) WO2011139118A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102014922B1 (en) * 2014-08-13 2019-08-27 (주)뉴트리 Composition for improving digestive functions comprising glabridin from Liquorice
CN104622989A (en) * 2015-01-15 2015-05-20 西安医学院 Traditional Chinese medicine compound sterilizing agent and preparation method thereof
CN105169204A (en) * 2015-09-29 2015-12-23 济南邦文医药科技有限公司 Traditional Chinese medicine composition for treating gastrointestinal motility dysfunction after ventriculo-peritoneal shunt operation
CN111214578A (en) * 2020-03-17 2020-06-02 苏州梅氏健康产业管理有限公司 Traditional Chinese medicine bathing liquid acting on digestive system and preparation method thereof
KR102407619B1 (en) 2020-03-24 2022-06-13 (주)에이앤바이오 Composition for improving cat hairball discharge

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003086441A1 (en) * 2002-04-12 2003-10-23 Pangenomics Co., Ltd Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases
WO2008019588A1 (en) * 2006-08-09 2008-02-21 Xiamen Guilong Investment Management Co., Ltd A chinese medicine composition for treating depression, neurasthenia and process thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1768816A (en) * 2004-05-29 2006-05-10 熊烈 Gastric motility medicine
KR100543354B1 (en) * 2005-05-17 2006-01-20 김성호 Herbal Extracts with Hepatitis Inhibitory Activity
KR101099004B1 (en) * 2009-03-13 2011-12-28 주식회사 사이그린 Composition for preventing or improving gastrointestinal diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003086441A1 (en) * 2002-04-12 2003-10-23 Pangenomics Co., Ltd Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases
WO2008019588A1 (en) * 2006-08-09 2008-02-21 Xiamen Guilong Investment Management Co., Ltd A chinese medicine composition for treating depression, neurasthenia and process thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEN, G. ET AL.: "Isoliquiritigenin, a Flavonoid from Licorice, plays a Dual Role in regulating Gastrointestinal Motility in vitro and in vivo", PHYTOTHERAPY RESEARCH, vol. 23, 2009, pages 498 - 506 *
CHO, E.J. ET AL.: "The role of Coptidis Rhizoma extract in a renal ischemia-reperfusion model", PHYTOMEDICINE, vol. 11, 2004, pages 576 - 584, XP029602828, DOI: doi:10.1016/j.phymed.2003.07.005 *
LEE, J. ET AL.: "Effect of Banhasasimtang Granule on Gastric Emptying in Rats", KOREAN JOURNAL OF ORIENTAL MEDICINE, vol. 27, no. 2, 2006, pages 471 - 479, XP053014829 *

Also Published As

Publication number Publication date
UA105685C2 (en) 2014-06-10
PH12012501555A1 (en) 2017-08-23
RU2012134195A (en) 2014-06-20
WO2011139118A2 (en) 2011-11-10
MY162542A (en) 2017-06-15
CN104800309A (en) 2015-07-29
KR101263191B1 (en) 2013-05-10
CN102858357A (en) 2013-01-02
BR112012020342A2 (en) 2016-05-03
RU2540511C2 (en) 2015-02-10
KR20110123114A (en) 2011-11-14

Similar Documents

Publication Publication Date Title
WO2010104309A3 (en) Compositions for preventing or improving gastrointestinal diseases
WO2010081720A3 (en) Compositions for the treatment of gastro-esofageal reflux disease (gerd)
WO2008007244A3 (en) Composition for improving eye health
WO2011139118A3 (en) A pharmaceutical composition and a health functional food composition for preventing, treating or improving a gastrointestinal dyskinetic disease
IL208106A (en) Use of polyethylene glycol-(peg)ylated igf-i variant for the manufacture of pharmaceutical compositions for the treatment, prevention and/or delay of neuromuscular disorders
WO2012050398A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating lung cancer
WO2011055931A3 (en) Composition for preventing or treating diseases caused by influenza viruses
WO2012091492A3 (en) Herbal extract, pharmaceutical composition including the same and health functional food including the same
WO2011074765A3 (en) Composition including fermented material for oriental medicine as an active ingredient for preventing and treating obesity or hyperlipidemia
CN104667229A (en) Traditional Chinese medicine for treating stomachache
CN102462800A (en) Traditional Chinese medicine composition for treating repeated cough
CN103550610B (en) A kind ofly treat Chinese medicine composition of due to weakness of spleen and stomach infantile diarrhea and preparation method thereof
CN104324351A (en) Traditional Chinese medicine preparation for treating gastro spasm
CN105012596A (en) Traditional Chinese medicine composition for treating ozostomia
CN105497825A (en) Traditional Chinese medicine formula for treating dyspepsia in the type of damp-turbid (-heat) with epigastric fullness inhibition
Yong-Deok et al. Change in composition of gut microbiota by exposure of natural medicines including Glycyrrhizae Radix in mice
CN103478362A (en) Traditional Chinese medicine tea capable of preventing and nursing stomach illness
CN102078370A (en) Traditional Chinese medicine powder for intestinal carbuncle abdominal pain
CN104138478A (en) Medicinal liquor for preventing and treating urticaria
CN102940868A (en) Chinese medicament for treating stomachache caused by deficiency and internal cold
CN102988651A (en) Chinese medicinal composition for treating stomach diseases and preparation method of Chinese medicinal composition
HRP20080202A2 (en) Herbal mixture and an active substance for enhancing immunity and treatment of alimentary tract and respiratory system
CN105477580A (en) Radix paeoniae alba flavored decoction for treating amebic dysentery
CN101708318A (en) Common yam rhizome formula for treating abdominal pain
CN105193965A (en) Composite traditional Chinese medicine for treating flagellosis

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180008408.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11777599

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 12012501555

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: A201209654

Country of ref document: UA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1201004055

Country of ref document: TH

ENP Entry into the national phase

Ref document number: 2012134195

Country of ref document: RU

Kind code of ref document: A

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 11/01/2013)

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012020342

Country of ref document: BR

122 Ep: pct application non-entry in european phase

Ref document number: 11777599

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 112012020342

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20120810